Genprex, Inc (GNPX) Stock Price

1.155 ▼ -0.145 (-11.15%)
Open: 1.28 Vol: 3.04K Day's range: 1.155 - 1.28 Apr 20, 15:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
GNPX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.16▼ 1.16▼ 1.16▼ 1.25▼ 1.39▼
MA10 1.16▼ 1.17▼ 1.22▼ 1.26▼ 1.66▼
MA20 1.16▼ 1.23▼ 1.27▼ 1.51▼ 2.00▼
MA50 1.20▼ 1.27▼ 1.26▼ 1.82▼ 1.58▼
MA100 1.26▼ 1.26▼ 1.38▼ 2.16▼ 1.28▼
MA200 1.27▼ 1.44▼ 1.66▼ 1.87▼ 16.69▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.003▲ -0.008▼ -0.017▼ -0.010▼ -0.174▼
RSI 25.247▼ 25.730▼ 29.187▼ 27.138▼ 42.598▼
STOCH 83.333▲ 3.191▼ 3.352▼ 22.448     5.565▼
WILL %R -100.000▼ -100.000▼ -100.000▼ -99.254▼ -99.754▼
CCI -324.074▼ -70.642     -83.794     -85.808     -136.935▼
Latest Filters Detected On GNPX
▼ RSI $GNPX RSI(14) Crossed Below 30 Set Alert
MA $GNPX Price Crossed Below MA(7) Set Alert
CDL $GNPX Marubozu Candlestick Pattern Detected Set Alert
Genprex, Inc News
Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
Monday, April 20, 2026 04:38 AM
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...
Genprex Inc.
Friday, April 10, 2026 03:45 PM
Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company product is REQORSA immunogen therapy drug for ...
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
Wednesday, March 18, 2026 05:00 AM
AUSTIN, Texas, March 18, 2026 /PRNewswire/ -- Genprex, Inc. (GNPX) ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for ...
GNPX historical stock data
date open high low close volume
20/04/26 1.28 1.28 1.155 1.155 963,065
17/04/26 1.30 1.3485 1.29 1.30 372,435
16/04/26 1.34 1.35 1.27 1.30 455,684
15/04/26 1.21 1.30 1.21 1.28 337,113
14/04/26 1.23 1.27 1.21 1.21 248,928
13/04/26 1.18 1.2977 1.17 1.21 495,741
10/04/26 1.30 1.34 1.15 1.15 604,924
09/04/26 1.29 1.355 1.27 1.30 347,675
08/04/26 1.39 1.44 1.2602 1.31 631,505
07/04/26 1.46 1.46 1.32 1.37 310,052
Quote Details
52wk Low:0.14
52wk High:12.97
Vol:3.04K
Avg Vol(3m):8.9M
1Y Chng:+295.01%
1M Chng:-41.67%
Add to Watch List
More Information
Index US Composite
Market Cap. 11.76M